NOT FOR DISTRIBUTION

Market Cap

HK$276.1m

Last Updated

2021/04/11 10:17 UTC

Data Sources

Company Financials

Executive Summary

Sanai Health Industry Group Company Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People’s Republic of China. More Details


Snowflake Analysis

Weak fundamentals or lack of information.

Share Price & News

How has Sanai Health Industry Group's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 1889 is less volatile than 75% of Hong Kong stocks over the past 3 months, typically moving +/- 0% a week.

Volatility Over Time: Insufficient data to determine 1889's volatility change over the past year.


Market Performance


7 Day Return

0%

1889

0.8%

HK Pharmaceuticals

-1.1%

HK Market


1 Year Return

n/a

1889

21.2%

HK Pharmaceuticals

28.6%

HK Market

Return vs Industry: Insufficient data to determine how 1889 performed against the Hong Kong Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how 1889 performed against the Hong Kong Market.


Shareholder returns

1889IndustryMarket
7 Day0%0.8%-1.1%
30 Day0%0.7%-1.8%
90 Day0%10.0%3.4%
1 Yearn/a23.0%21.2%33.5%28.6%
3 Year-55.0%-55.0%-14.3%-19.1%4.0%-6.9%
5 Year-72.7%-72.7%79.2%62.4%48.7%23.7%

Long-Term Price Volatility Vs. Market

How volatile is Sanai Health Industry Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Sanai Health Industry Group undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether Sanai Health Industry Group is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Sanai Health Industry Group has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Future Growth

How is Sanai Health Industry Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

18.2%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sanai Health Industry Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Sanai Health Industry Group performed over the past 5 years?

10.4%

Historical Pharmaceuticals & Biotech annual earnings growth


Earnings and Revenue History

Quality Earnings: 1889 has a high level of non-cash earnings.

Growing Profit Margin: Insufficient data to determine if 1889's profit margins have improved over the past year.


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if 1889's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare 1889's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if 1889's earnings growth over the past year exceeded the Pharmaceuticals industry average.


Return on Equity

High ROE: 1889 has a negative Return on Equity (0%), as it is currently unprofitable.


Financial Health

How is Sanai Health Industry Group's financial position?


Financial Position Analysis

Short Term Liabilities: Insufficient data to determine if 1889's short term assets cover its short term liabilities.

Long Term Liabilities: Insufficient data to determine if 1889's short term assets cover its long term liabilities.


Debt to Equity History and Analysis

Debt Level: Insufficient data to calculate 1889's debt to equity ratio to determine if it is satisfactory.

Reducing Debt: Insufficient data to determine if 1889's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: Insufficient data to determine if 1889's debt is well covered by operating cash flow.

Interest Coverage: Insufficient data to determine if 1889's interest payments on its debt are well covered by EBIT.


Balance Sheet


Dividend

What is Sanai Health Industry Group current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate 1889's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 1889's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 1889's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 1889's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: 1889 is not paying a notable dividend for the Hong Kong market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 1889's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.8yrs

Average board tenure


CEO

Sanai Health Industry Group has no CEO, or we have no data on them.


Board Members

Experienced Board: 1889's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Sanai Health Industry Group Company Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Sanai Health Industry Group Company Limited
  • Ticker: 1889
  • Exchange: SEHK
  • Founded: 2006
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: HK$276.050m
  • Shares outstanding: 3.07b
  • Website: https://www.1889hk.com

Number of Employees


Location

  • Sanai Health Industry Group Company Limited
  • Nanyang Plaza
  • 7th Floor
  • Kwun Tong
  • Kowloon
  • Hong Kong

Listings


Biography

Sanai Health Industry Group Company Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People’s Republic of China. It operates through three s...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/04/11 10:17
End of Day Share Price2021/04/09 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.